-
Information-Publications
-
Differential Degradation of TRA2A and PYCR2 Mediated by Ubiquitin E3 Ligase E4BDetails -
The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsisDetails -
Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferaseDetails -
Dual guide RNA-mediated concurrent C&G-to-T&A and A&T-to-G&C conversions using CRISPR base editorsDetails -
TET2 suppresses VHL deficiency-driven clear cell renal cell carcinoma by inhibiting HIF signalingDetails -
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBDDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
